hCG in men: the signal that keeps your testicle working

hCG en hombres: la señal que mantiene tu testículo trabajando

What your blood test cannot see

When someone measures your testosterone, they measure what is circulating in your blood. That is useful information. It is not where the important work happens.

The testosterone needed to make sperm is not in your arm. It is inside the testicle, in the fluid surrounding the tubules where sperm is produced. And the concentration there is on a different scale entirely.

In 2005, a team at the University of Washington measured both in 29 men with normal reproductive physiology. They did not estimate it: they drew fluid from the testicle with a fine needle and analyzed it.

That number is worth sitting with. Your testicle does not receive testosterone from the blood and make do. It builds it on site, and keeps it concentrated exactly where it is needed.

This explains something that confuses a lot of men. You can have perfectly normal blood testosterone and, at the same time, have sperm production stalled. These are not one system measured twice. They are two different things, and one does not tell you about the other.

The key, the lock, and why hCG fits

That factory does not run unprompted. It needs an order, and the order comes from above.

Your pituitary — a pea-sized gland at the base of the brain — sends two messengers to the testicle. One is LH, which speaks to the cells that make testosterone. The other is FSH, which speaks to the cells that sustain sperm production.

LH arrives at the testicle and docks onto a receptor, like a key in its lock. That docking is the signal to switch on.

This is where hCG comes in. hCG and LH resemble each other so closely that they open the same lock. The receptor does not really tell them apart. So a dose of hCG does to the testicle what an order of LH would do: it switches on testosterone production inside the organ.

It also has a practical advantage over LH itself — it lasts far longer in circulation. One injection every other day is enough to hold the signal, instead of the short pulses the brain sends several times a day.

Your body used this signal before labs existed

There is one detail about this molecule that most articles skip, and it is the one that earns the most trust.

hCG was not invented to stand in for LH. It is a pregnancy hormone. And through the first two trimesters, the mother's hCG is what drives the fetus's own sex hormone production. If that baby is male, this is the signal that starts his testicle for the first time in his life.

Put another way: before your pituitary took over, hCG was doing that job. It is the original signal.

That does not make it harmless or magic — it is a medication and it needs a physician — but it does explain why it works so directly. We are not forcing the testicle with something foreign to it. We are handing back a message it has known since before birth.

The blind spot of prescription testosterone

Prescription testosterone does what it promises. It raises blood testosterone and, in many men, improves energy, mood and libido. Nothing that follows takes that away.

But it has an effect worth understanding before you start, not after.

Your brain monitors circulating testosterone. When it arrives from outside, the brain concludes there is already enough and stops sending the order. LH falls. FSH falls. And because the factory inside the testicle depended on that order, it shuts down.

In the trial above, the men who received testosterone alone ended up with LH at 5% and FSH at 3% of where they started. Testosterone inside the testicle fell by 94%, from 1,234 to 72 nmol/L.

While that happens, the blood test looks better than ever. That is the blind spot: the number you watch goes up at precisely the moment the number you do not watch collapses.

The practical consequence is fertility. In hypogonadal men treated with testosterone alone, the literature describes roughly 40% reaching azoospermia — no sperm in the semen at all. In most men production returns after stopping, but how long it takes varies widely from one man to the next, and that makes any family plan with a date on it difficult.

This is why the guidance is firm on one point: exogenous testosterone is not for a man who is trying to conceive now.

What hCG did when someone actually measured

The good news is that this problem has a studied solution — and the study that measured it is the same one that opened this article.

All 29 men received the same injected testosterone. Then they were randomized into four groups: one on placebo and three on different hCG doses — 125, 250 or 500 IU — every other day for three weeks. At the end, the testicular fluid was measured again.

The result was a clean staircase:

Look at the gap between the first row and the third. It is the same testosterone treatment in both. The only thing that changed is whether the signal kept arriving.

And notice the dose it took: 250 IU. That is not a large dose. Keeping the factory running does not require pushing it — it only requires not cutting off the order.

That study measured hormones. The next question — whether this translates into actual sperm — was answered by another group, at Baylor, in 26 hypogonadal men who wanted to preserve fertility. They received their usual testosterone plus 500 IU of hCG every other day, and were followed with semen analyses.

It is a small, retrospective study, not a large trial. But the contrast with the 40% azoospermia you would expect without hCG is hard to ignore, and recent reviews report the same thing: hCG sustains intratesticular testosterone and sperm production even when exogenous testosterone has fully suppressed both brain signals.

When hCG works on its own

There is a second scenario, different from the first. It is not about protecting a factory that was working. It is about switching one on for the first time.

This is the case for men whose problem is not the testicle but the signal: the brain is not sending the order. The testicle is healthy and waiting. That condition is called hypogonadotropic hypogonadism, and it is the situation in which hCG carries an approved indication.

A multicenter trial followed 49 such men on hCG alone for 16 weeks, then added FSH for those who still had no sperm. The numbers tell the story well:

• On hCG alone, testosterone went from roughly 1.1 ng/mL to 6.3 ng/mL in four months. The factory started up.
• Testicular volume rose from 11.4 to 24.0 mL. The organ grew as it went back to work.
• But 61% still had no sperm in the semen, with testosterone already normal.
• Once FSH was added, 47% of those men reached measurable sperm counts, after a median of about five and a half months.

That third line is the most useful lesson in the study, and it holds for anyone looking at this topic: normal testosterone is not the same as restored fertility. hCG covers one of the two signals. The other, FSH, is sometimes also needed. That is the kind of decision only a physician can make looking at your case, with semen actually measured — not a web page.

The trial left one more practical clue: men who started with smaller testicles took longer, and those with a history of undescended testes as children had a harder time getting there. The starting point matters, and knowing it up front spares a lot of frustration.

An approved medication, with an indication in writing

This is worth saying plainly, because it changes the conversation: hCG is not a supplement or an experimental peptide.

Chorionic gonadotropin is FDA-approved and carries its own prescribing information. Among its approved indications, two are for males:

• Selected cases of hypogonadotropic hypogonadism in males — that is, hypogonadism secondary to a pituitary deficiency.
• Prepubertal cryptorchidism not due to anatomical obstruction, in children aged 4 to 9.

That means its mechanism, its dosing and its safety profile went through formal regulatory review. That is not a small thing: in the world of peptides, very few can say the same.

Using it outside those indications — for example, alongside testosterone to protect fertility, as in the studies above — is off-label use. It is described in the literature and covered by serious reviews, but it remains an individual medical decision, not a protocol to copy off the internet.

What hCG does not do (and the label says it in capitals)

If you have searched for hCG online, the first thing you found probably had nothing to do with any of the above. You were told about the "hCG diet."

Here is what the FDA-approved label says, literally in capital letters in the document:

There is no way to soften that, and we would not want to. If weight loss is what brought you to this page, hCG is not the tool. Whatever comes off on those diets comes off from eating 500 calories a day, and that can be done — with all of its risks — without any injection at all.

We tell you because your trust is worth more than a sale. And because for weight loss there genuinely are tools with real evidence behind them; we cover those below and across the rest of the guide.

So your expectations are the right ones

If hCG turns out to fit your case, these are the things worth being clear about from day one:

• It protects a function; it does not promise a feeling. The best-documented thing about hCG alongside testosterone is that it maintains sperm production. Whether it will make you feel different is a separate question, and the studies do not answer it.
• The fertility studies are small. The 26-man study is retrospective, not a large randomized trial. The direction is consistent; the size is modest.
• The timeline is measured in months. With hCG alone, testosterone took about four months to normalize, and sperm, when it appeared, took a median of about five and a half months. This is not a matter of weeks.
• Sometimes hCG is not enough. In the trial, 61% still had no sperm with testosterone already normal. FSH had to be added — and even then, fewer than half responded.
• Dose matters in both directions. The study showed a staircase: too little falls short, and 500 IU pushed the internal concentration above baseline. This is not a medication to eyeball.
• Estradiol is what gets watched. As testosterone inside the testicle rises, its conversion to estradiol can rise too. That is one of the reasons this is done with follow-up.

Who is this NOT for?

This part is not negotiable, and we are leaving it complete:

• Anyone looking to lose weight. As covered above, the approved label rules it out explicitly.
• Anyone with a current or past hormone-dependent cancer, including prostate or breast. The label contraindicates use with tumors of the reproductive organs, breast or prostate.
• Anyone with a known allergy to chorionic gonadotropin or any of its components.
• Anyone with an uncontrolled non-gonadal endocrine condition — thyroid or adrenal, for example. That gets controlled first.
• Anyone with primary testicular failure. If the testicle cannot respond, sending it more signal does not change the outcome. hCG helps when the problem is the signal, not the factory.
• Children and adolescents, outside the specific pediatric indication and always with a specialist.
• Anyone who does not want follow-up. This is done with monitoring. Without it, it is not done.

And one reminder that applies to everything you read here: do not start, change or stop any medication on your own, not even on the strength of a well-cited article. What decides is your case, seen by your physician.

GLP-1 programs with FDA-approved medications (Wegovy®, Foundayo™, Ozempic®) from $149/month, by telemedicine, in Spanish and English

If what brought you here was weight — and hCG has just been ruled out for that — we can help with that part, using tools that have the evidence hCG lacks in that area. Real clinical supervision, in English and Spanish, with continuous follow-up. Cancel whenever you want, in one click.

And if your interest is the hormonal side, the path is the same: once you start your program, a licensed physician reviews your case — habits, stress, sleep and medical history — and orders labs only if they consider it necessary.

Eligibility is determined by medical evaluation. Individual results vary and are not guaranteed.

Frequently asked questions

What exactly is hCG?

It is a hormone — human chorionic gonadotropin. It resembles LH, the messenger your brain sends to the testicle, closely enough to open the same lock and give the same order: make testosterone inside the testicle. It is also the hormone that drives a fetus's hormone production through the first months of pregnancy.

Why does testosterone "inside the testicle" matter?

Because that is the testosterone needed to produce sperm, and it is far higher than the level in blood. In healthy men, blood testosterone was just 1.2% of the concentration inside the testicle. Your blood test does not report on that one.

Does prescription testosterone cause infertility?

Not permanently in most cases, but it does suppress sperm production while it is being used: the literature describes azoospermia in roughly 40% of treated men. Production usually returns after stopping, though how long that takes varies widely. This is why it is not indicated for a man trying to conceive now.

Does hCG prevent that?

In the available studies, it did. Adding low-dose hCG kept testosterone inside the testicle in the normal range, and in a follow-up of 26 men on testosterone plus hCG, none became azoospermic, with semen parameters stable for over a year. These are small studies, but consistent ones.

How much hCG does it take?

Less than most people assume. In the dose-response trial, 250 IU every other day was enough to leave the internal concentration within 7% of baseline. The figures in the studies are not a prescription: your physician decides the dose.

Does hCG work for weight loss?

No. The FDA-approved label says so in capital letters: it has not been demonstrated effective in treating obesity, and it has no known effect on fat mobilization, appetite or body fat distribution. Whatever comes off on the so-called "hCG diet" comes off from extreme calorie restriction.

Is it FDA-approved for men?

Yes, for specific indications: selected cases of hypogonadotropic hypogonadism in males, and prepubertal cryptorchidism in children aged 4 to 9. Using it alongside testosterone to protect fertility is off-label use, described in the literature and decided case by case.

Can it be used on its own instead of testosterone?

In men whose problem is the signal rather than the testicle, yes, and it raises testosterone meaningfully: in one trial it went from around 1.1 to 6.3 ng/mL in four months, with testicular volume rising from 11.4 to 24.0 mL. But 61% still had no sperm with testosterone already normal, and FSH had to be added.

How long before anything shows up?

Months, not weeks. Testosterone took about four months to normalize in the hCG-alone trial, and sperm appeared after a median of about five and a half months once FSH was added. Men starting with smaller testicles generally take longer.

Do I need labs before starting?

Once you start your program, a licensed physician reviews your case — habits, stress, sleep and medical history — and orders labs only if they consider it necessary. It is not automatic and not required for everyone.

Do you offer care in Spanish?

Yes. All of our content and our care are available in Spanish.

Sources

• Coviello AD, Matsumoto AM, Bremner WJ, et al. Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression. J Clin Endocrinol Metab. 2005;90(5):2595-2602. — DOI · via PubMed
• Hsieh TC, Pastuszak AW, Hwang K, Lipshultz LI. Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy. J Urol. 2013;189(2):647-650. — DOI · via PubMed
• Bouloux PM, Nieschlag E, Burger HG, et al. Induction of spermatogenesis by recombinant follicle-stimulating hormone (Puregon) in hypogonadotropic azoospermic men who failed to respond to human chorionic gonadotropin alone. J Androl. 2003;24(4):604-611. — DOI · via PubMed
• Ramasamy R, Armstrong JM, Lipshultz LI. Preserving fertility in the hypogonadal patient: an update. Asian J Androl. 2015;17(2):197-200. — DOI · via PubMed
• Naelitz BD, Momtazi-Mar L, Vallabhaneni S, et al. Testosterone replacement therapy and spermatogenesis in reproductive age men. Nat Rev Urol. 2025;22(10):703-719. — DOI · via PubMed
• Hochu G, Geyer-Kim I, Kim E. Preserving spermatogenesis in testosterone deficiency: innovations in replacement and stimulatory therapies. Transl Androl Urol. 2025;14(12):3975-3987. — DOI · via PubMed
• Pitteloud N, Dwyer A. Hormonal control of spermatogenesis in men: therapeutic aspects in hypogonadotropic hypogonadism. Ann Endocrinol (Paris). 2014;75(2):98-100. — DOI · via PubMed
• U.S. Food and Drug Administration. PREGNYL (chorionic gonadotropin for injection, USP) — Prescribing Information. — accessdata.fda.gov

Your trust is worth more than a sale.

More information →

This article is informational and is not medical advice. SCTS1 does not prescribe medications. All medical care, prescriptions and treatment plans are provided by licensed physicians through our partner platform, and preparations are dispensed by licensed pharmacies. Eligibility is determined by a licensed provider through medical evaluation. Chorionic gonadotropin is FDA-approved for selected cases of hypogonadotropic hypogonadism in males and for prepubertal cryptorchidism; its use alongside testosterone to preserve fertility is off-label and is an individual medical decision. The FDA states explicitly that hCG is not effective for weight loss. The doses mentioned correspond to those studied in the cited literature and do not replace your physician's instructions; do not start or change any medication on your own. Individual results vary and are not guaranteed.